Rocket Pharmaceuticals Inc (RCKT)
23.40
-0.26
(-1.10%)
USD |
NASDAQ |
May 16, 16:00
23.41
+0.01
(+0.04%)
After-Hours: 20:00
Rocket Pharmaceuticals Cash from Operations (Quarterly): -56.86M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -56.86M |
| December 31, 2023 | -29.34M |
| September 30, 2023 | -57.15M |
| June 30, 2023 | -50.87M |
| March 31, 2023 | -57.56M |
| December 31, 2022 | -56.02M |
| September 30, 2022 | -43.86M |
| June 30, 2022 | -39.04M |
| March 31, 2022 | -39.22M |
| December 31, 2021 | -30.94M |
| September 30, 2021 | -27.41M |
| June 30, 2021 | -38.53M |
| March 31, 2021 | -24.28M |
| December 31, 2020 | -13.11M |
| September 30, 2020 | -17.25M |
| June 30, 2020 | -22.03M |
| March 31, 2020 | -22.24M |
| December 31, 2019 | -19.73M |
| September 30, 2019 | -10.85M |
| June 30, 2019 | -18.10M |
| March 31, 2019 | -15.98M |
| Date | Value |
|---|---|
| December 31, 2018 | -20.81M |
| September 30, 2018 | -11.64M |
| June 30, 2018 | -9.738M |
| March 31, 2018 | -11.60M |
| December 31, 2017 | -16.14M |
| September 30, 2017 | -4.094M |
| June 30, 2017 | -2.156M |
| March 31, 2017 | -3.723M |
| December 31, 2016 | -11.14M |
| September 30, 2016 | -9.132M |
| June 30, 2016 | -8.003M |
| March 31, 2016 | -8.993M |
| December 31, 2015 | -7.039M |
| September 30, 2015 | -4.327M |
| June 30, 2015 | -4.057M |
| March 31, 2015 | -1.993M |
| December 31, 2014 | -2.994M |
| September 30, 2014 | -2.837M |
| June 30, 2014 | -2.057M |
| March 31, 2014 | -1.855M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-57.56M
Minimum
Mar 2023
-10.85M
Maximum
Sep 2019
-33.72M
Average
-30.14M
Median
Cash from Operations (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 18.73M |
| ADMA Biologics Inc | -2.218M |
| Geron Corp | -62.25M |
| Madrigal Pharmaceuticals Inc | -149.16M |
| United Therapeutics Corp | 376.50M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 35.03M |
| Cash from Financing (Quarterly) | 1.184M |
| Free Cash Flow | -209.70M |
| Free Cash Flow Per Share (Quarterly) | -0.6295 |
| Free Cash Flow Yield | -10.24% |